Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice. - Wikidata - wikimedia - TriplyDB

Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice.

Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice.

http://www.wikidata.org/entity/Q38311828

about

AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231 Synthesis and evaluation of novel gonadotropin-releasing hormone receptor-targeting peptides.Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.Introduction of D-phenylalanine enhanced the receptor binding affinities of gonadotropin-releasing hormone peptides.Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells.

P2860

Q34274245-1DC610D4-4362-457F-81FC-2F9AD652B58A Q34486740-07DC1572-CDB8-4590-88C5-D3D85851CE15 Q35169098-771E8306-5407-4B14-B66D-F8D43C713330 Q36202016-C5BB9BE3-C2B9-4FFC-848A-BE1ECBF85B9F Q37584911-BB4F70B1-D49A-48C2-A836-4DEEDDB672E6 Q38007373-F798D0D1-E016-4A9B-A752-96226B9F3726 Q48656281-93D13033-4A42-4923-8448-3C5F68BE3445 Q50865530-B6BFFF55-D0FA-4250-8E8D-5643D06BC76D

P2860

Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice.

http://www.wikidata.org/entity/Q38311828

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Administration of a targeted c ...... n breast cancers in nude mice.

@en

type

label

Administration of a targeted c ...... n breast cancers in nude mice.

@en

prefLabel

Administration of a targeted c ...... n breast cancers in nude mice.

@en

P1433

Q38311828-27276C50-4F34-4980-9677-09E5449CC8D0

P1476

Q38311828-51F503E8-6771-40A2-9E10-569635D1A9CB

P2093

Q38311828-25F9C208-06F3-47AF-BD5E-EF3752382E37

Q38311828-67C59437-41AF-48E4-AE51-3A19A02F8B2A

Q38311828-9716304F-2F10-443E-AFF6-423AD4848A9B

Q38311828-9DD1087B-A1D8-4AFD-A8BE-A473A385E523

P2860

Q38311828-0E212153-5175-4195-9887-359420EAC4FD

Q38311828-3D59FA3C-F0C4-4F75-BF50-C87FF03B4021

Q38311828-3DD42725-B74C-464F-9B34-F0B683886D46

Q38311828-55620C44-68C7-4F67-B8B5-F2D4346B06D1

Q38311828-6FBCD85B-E0C7-43E1-958A-4DB72DEC0504

Q38311828-80DA22BC-98EC-41C6-BD23-2C292BBB886C

Q38311828-8B539698-2EA9-45E2-9D8D-DDBDCEC28113

Q38311828-9600CFD0-A6BF-41A0-825D-E4DCD7EA66FE

Q38311828-C66D099F-098E-4A07-83B8-12D1CFE5F2EC

Q38311828-C7535EC0-F538-4014-AA85-83A23E276FC1

P2888

Q38311828-087662F8-95EC-45CA-BFD9-102862C7A6F4

P304

Q38311828-4B9890FB-C59A-4B84-9E2B-287D29F35D21

P31

Q38311828-60529BBA-E790-4840-82B9-603A779D0115

P356

Q38311828-DF573190-F80C-4C9A-ADED-75BB6C51A74B

P407

Q38311828-9F96517D-33B0-4E9F-917F-C5788D4B2CA3

P433

Q38311828-40D8DD01-2953-4FCB-A696-F4F17847D6D0

P478

Q38311828-48A14C09-5C63-4B43-882B-E357EB91AA08

P50

Q38311828-A1CF7DD8-CAEF-4EEF-9EE2-FB4BC9F3199B

Q38311828-A2260B9D-53B5-4BEE-85DC-4190063C5978

P577

Q38311828-9935D28B-2192-4436-8D25-27009591F11A

P6179

Q38311828-B1A5191D-8016-4EAB-B0C9-68B8CEDBB0F7

P698

Q38311828-F79013FD-1354-42D7-9073-2009022B876B

P356

A:1006352401912

P1433

Breast Cancer Research and Treatment

P1476

Administration of a targeted c ...... an breast cancers in nude mice

@en

P2093

A Nagy

http://www.w3.org/2001/XMLSchema#string

G Halmos

http://www.w3.org/2001/XMLSchema#string

K Groot

http://www.w3.org/2001/XMLSchema#string

Z Kahán

http://www.w3.org/2001/XMLSchema#string

P2860

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

Ligand: a versatile computerized approach for characterization of ligand-binding systems

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

Cancer statistics, 1998.

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone.

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin.

Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions.

Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro.

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*

P2888

a:1006352401912

P304

255-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/A:1006352401912

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Jose M Arencibia

P577

2000-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029361790

http://www.w3.org/2001/XMLSchema#string

P698

10832595

http://www.w3.org/2001/XMLSchema#string